Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

BioNTech (United States) | Researchclopedia

Back to institutions

BioNTech (United States)

Cambridge, Massachusettscompany

303

Works

52,931

Citations

100

h-index

Top Research Topics

Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers SARS-CoV-2 and COVID-19 Research

Top Researchers

Christian Weber Boston University

1,837 works99,600 citationsh-index: 160

Recent Research

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial

Byoung Chul Cho,Rama Balaraman,et al.

20260 citations

CAR-T cell therapy research

vaccines and immunoinformatics approaches

Monoclonal and Polyclonal Antibodies Research

RNA Interference and Gene Delivery

Lung Cancer Treatments and Mutations

CRISPR and Genetic Engineering

Immune Cell Function and Interaction

Lung Cancer Research Studies

COVID-19 Clinical Research Studies

Everett E. Vokes University of Illinois Chicago

1,235 works79,178 citationsh-index: 119

Uğur Şahin Johannes Gutenberg University Mainz

722 works69,935 citationsh-index: 103

Özlem Türeci Johannes Gutenberg University Mainz

419 works55,125 citationsh-index: 80

David C.S. Huang The University of Melbourne

575 works45,424 citationsh-index: 101

Alexandra C. Walls Howard Hughes Medical Institute

135 works36,354 citationsh-index: 63

Cross-competition shapes CD8+ T cell hierarchies and fate after cancer neoantigen RNA vaccination

Lélia Delamarre,Mark McCarron,et al.

20260 citations

439TiP ROSETTA Lung-01: A phase III, two-stage trial of pumitamig, a PD-L1 × VEGF-A bispecific antibody, plus chemotherapy versus atezolizumab + chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer

M. Reck,Özgür ÖZYILKAN,et al.

20260 citations

3O Anti-tumor activity of gotistobart compared to docetaxel in patients with metastatic squamous non-small cell lung cancer (sqNSCLC) progressing on PD-(L)1 inhibitors: Stage 1 PRESERVE-003 phase III trial

K. He,B.C. Cho,et al.

20260 citations

69P First-line pumitamig (PD-L1 × VEGF-A bsAb) monotherapy in PD-L1+ non-squamous and squamous non-small cell lung cancer: Data from a phase Ib/IIa trial in China

L. Zhang,D. Lv,et al.

20260 citations

149TiP ROSETTA Lung-02: A global phase II/III, randomized, open-label trial of pumitamig, a PD-L1 × VEGF-A bispecific antibody, in combination with chemotherapy in patients (pts) with first-line non-small cell lung cancer

S. Peters,Y. Lee,et al.

20260 citations